Corteva (CTVA) risk factors, FY2024 10-K

Corteva's FY2024 10-K, filed Feb 14, 2025, lists 28 risk factors in 4 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
284 groups
Section length
9k wordsItem 1A

Corteva's biggest risks in the FY2024 10-K

  • Regulatory approval hurdles and compliance demands dominate seed and crop protection product commercialization.
  • Complex separation agreements and tax liabilities tied to DuPont and Dow create ongoing financial risks.
  • Intellectual property protection, patent expirations, and competitive pressures significantly impact market positioning.

The risks most specific to Corteva

  • Risks Related to our Industry

    Corteva may not be able to obtain or maintain the necessary regulatory approvals for some of its products, including its Seed and Crop Protection products, which could restrict its ability to sell those products in some markets

    Corteva may fail to obtain necessary regulatory approvals for its Seed and Crop Protection products, restricting market sales.

  • Risks Related to our Industry

    The degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products and technologies can affect Corteva’s sales and results of operations by affecting planting approvals, regulatory requirements and customer purchase decisions

    Public acceptance of biotechnology and agricultural products can affect planting approvals, regulatory requirements, and customer purchase decisions.

  • Risks Related to our Industry

    Corteva’s sales to its customers may be adversely affected should a company successfully establish an intermediary platform for the sale of Corteva’s products or otherwise position itself between Corteva and its customers

    Establishment of intermediary sales platforms could negatively impact Corteva's direct sales through Pioneer and retail channels.

  • Risks Related to Our Operations

    EIDP has identified a material weakness in its internal control over financial reporting, which could negatively impact the accurate and timely reporting of its results of operations and financial condition

    EIDP identified a material weakness in internal control over financial reporting regarding intercompany cash flow classification and restated results.

  • Risks Related to Our Intellectual Property

    Restrictions under the intellectual property cross-license agreements limit Corteva’s ability to develop and commercialize certain products and services and/or prosecute, maintain and enforce certain intellectual property

    Intellectual property cross-license agreements with DuPont and Dow restrict Corteva's ability to develop, commercialize, and enforce certain products and services.

  • Risks Related to The Separation

    DuPont is currently disputing with Corteva certain provisions of the Separation Agreement and Tax Matters Agreement

    DuPont is currently disputing certain provisions of the Separation Agreement and Tax Matters Agreement with Corteva.

  • Risks Related to The Separation

    The company is subject to continuing contingent tax-related liabilities of DowDuPont following the Distribution

    Corteva remains subject to continuing contingent tax-related liabilities and obligations originating from DowDuPont following the distribution.

All 28 risk factors

Headings as the filing states them, in filing order.

Risks Related to our Industry

  1. 01Corteva may not be able to obtain or maintain the necessary regulatory approvals for some of its products, including its Seed and Crop Protection products, which could restrict its ability to sell those products in some markets
  2. 02Regulatory and legislative requirements affect the development, manufacture and distribution of Corteva’s products, including the testing and planting of seeds containing Corteva’s biotechnology traits and the import of crops grown from those seeds, and non-compliance can harm Corteva’s sales and profitability
  3. 03The successful development and commercialization of Corteva's pipeline products will be necessary for Corteva's growth
  4. 04ITEM 1A. RISK FACTORS, continued
  5. 05The degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products and technologies can affect Corteva’s sales and results of operations by affecting planting approvals, regulatory requirements and customer purchase decisions
  6. 06Changes in agricultural and related policies of governments and international organizations may prove unfavorable
  7. 07Climate change and unpredictable seasonal and weather factors could impact Corteva’s sales and earnings
  8. 08Corteva’s business is subject to various competition and antitrust, rules and regulations around the world, and as the size of its business grows, scrutiny of its business by legislators and regulators in these areas may intensify
  9. 09Corteva participates in an industry that is highly competitive and has undergone consolidation, which could increase competitive pressures
  10. 10Corteva’s sales to its customers may be adversely affected should a company successfully establish an intermediary platform for the sale of Corteva’s products or otherwise position itself between Corteva and its customers

Risks Related to Our Operations

  1. 11Our business, financial condition and results of operations could be materially affected by disruptions in the global economy caused by geopolitical and military conflicts
  2. 12Volatility in Corteva’s input costs, which include raw materials and production costs, could have a significant impact on Corteva’s business, results of operations and financial condition
  3. 13Corteva’s operations outside the United States are subject to risks and restrictions, which could negatively affect Corteva’s business, results of operations and financial condition
  4. 14Corteva’s business, results of operations and financial condition could be adversely affected by industrial espionage and other disruptions to its supply chain, information technology or network systems
  5. 15Corteva’s business, results of operations and financial condition could be adversely affected by environmental, litigation and other commitments and contingencies
  6. 16Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization
  7. 17Corteva’s customers may be unable to pay their debts to Corteva, which could adversely affect Corteva’s results
  8. 18Failure to effectively manage acquisitions, divestitures, strategic investments, restructurings, cost savings initiatives and other portfolio actions may not have the results anticipated
  9. 19Corteva’s liquidity, business, results of operations and financial condition could be impaired if it is unable to raise capital through the capital markets or short-term debt borrowings
  10. 20Increases in pension and other post-employment benefit plan funding obligations may adversely affect Corteva’s results of operations, liquidity or financial condition
  11. 21Global or regional health pandemics or epidemics could negatively impact the company's business, financial condition and results of operations
  12. 22EIDP has identified a material weakness in its internal control over financial reporting, which could negatively impact the accurate and timely reporting of its results of operations and financial condition
  13. 23Sentiment towards sustainability matters could adversely affect our stock price, results of operations, and access to capital

Risks Related to Our Intellectual Property

  1. 24Enforcing Corteva’s intellectual property rights, or defending against intellectual property claims asserted by others, could materially affect Corteva’s business, results of operations and financial condition
  2. 25Corteva’s business may be adversely affected by the availability of counterfeit products
  3. 26Restrictions under the intellectual property cross-license agreements limit Corteva’s ability to develop and commercialize certain products and services and/or prosecute, maintain and enforce certain intellectual property

Risks Related to The Separation

  1. 27DuPont is currently disputing with Corteva certain provisions of the Separation Agreement and Tax Matters Agreement
  2. 28The company is subject to continuing contingent tax-related liabilities of DowDuPont following the Distribution

Other Corteva 10-Ks

  • FY2025 10-K risk factors
    30 risks4 new2 dropped5 reworded

    Corteva plans to spin off its seed and crop protection businesses into two standalone public companies.

    Filed Feb 12, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.